Semaglutide is studied and approved for three things: type 2 diabetes (Ozempic/Rybelsus), chronic weight management (Wegovy), and cardiovascular risk reduction the broadest indication set in this pair
The search for GLP- 1 receptor agonists to treat T2DM was sparked by studies showing the insulinotropic and glucose-lowering effects of GLP- 1 in beta cells, as well as the hyperglycemic effects of GLP- 1 receptor antagonism [44]
Ponziani FR, Zocco MA, Cerrito L, Gasbarrini A, Pompili M
Further information is available via NHS medicines information pages and NICE guidance at nice.org.uk
Route of Administration: Given through IV (intravenous) or IM (intramuscular) injection Methylcobalamin Injection (B12) FAQs Doctors may stop B12 injections if a patients levels are stabilized, if they switch to oral supplements, or if there's no clear deficiency